Drug Profile
PF 4764793
Alternative Names: PF-00241939; PF-04764793; PF-241939; PF-4764793Latest Information Update: 15 Nov 2011
Price :
$50
*
At a glance
- Originator Pfizer
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 10 Nov 2011 Discontinued - Phase-I for Asthma in Singapore (Inhalation)
- 11 May 2011 Pfizer completes a phase I trial in Healthy volunteers in Singapore (NCT01272375)